Demonstrates the inhibitory potential of phosphonoproline–proline bioisosteres on PPEP-1, implying a new method for targeting Clostridioides difficile.
The design, synthesis and preliminary inhibitory activity of novel phosphonoproline–proline-containing pseudohexapeptides against PPEP-1, a metalloprotease secreted by Clostridioides difficile, is reported. Remarkably, the P ( R ) -configured phosphonoproline–proline hexapeptide bioisostere of the synthetic heptapeptide Ac-EVNPPVP-NH 2 is 1000 times more active than the corresponding P ( S ) analogue as measured by a FRET assay, which represents a binding energy of about 12 kJ/mol. Placing an embedded enantiopure phosphonoproline unit to replace a proline within a peptidic construct constitutes a promising venue in the design of proline-containing metalloenzyme inhibitors.
No takes yet. Share an insight, caveat, or question.
Toto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: